These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12970259)

  • 21. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen's protection against heart disease may be overstated.
    Indian Med Trib; 1994 Jul; 2(11):6. PubMed ID: 12179178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormones and heart disease--down, not out.
    Harv Heart Lett; 2002 Mar; 12(7):3-5. PubMed ID: 11916632
    [No Abstract]   [Full Text] [Related]  

  • 26. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?".
    Dören M; Greiser EM
    Am J Epidemiol; 2007 Dec; 166(12):1479-80; author reply 1481-2. PubMed ID: 17977898
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: "invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?".
    Rosenberg L
    Am J Epidemiol; 2007 Dec; 166(12):1480-1; author reply 1481-2. PubMed ID: 17993654
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiology and the menopause: a global overview.
    Barrett-Connor E
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormones and heart disease.
    Kent S
    Geriatrics; 1979 Jun; 34(6):97-102. PubMed ID: 447079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estrogens for treatment of osteoporoses].
    Higuchi T; Tarakida A; Abe K; Mizunuma H
    Nihon Rinsho; 2009 May; 67(5):954-9. PubMed ID: 19432116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.
    Hodis HN; Mack WJ; Lobo RA
    Circulation; 2003 Jul; 108(1):e5; author reply e5. PubMed ID: 12847059
    [No Abstract]   [Full Text] [Related]  

  • 34. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
    Stevenson JC
    Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
    Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy and heart disease: replacing dogma with data.
    Herrington DM
    Circulation; 2003 Jan; 107(1):2-4. PubMed ID: 12515732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.